Advance your academic career, collaborate globally, and expand your network— join now !

Insop Shim

Prof. Insop Shim

Kyunghee University

Share Link

Share

Information

Insop Shim is currently working as a Professor in the Department of Medical Science at Kyung Hee University, Republic of Korea. He received his Ph.D. degree in Behavioral Neuroscience from the University of Illinois, USA, and completed his post-doctoral fellowship in the Department of Psychiatry, School of Medicine, University of Illinois. Prof. Insop Shim is a member of the Society for Neuroscience and has served as an organizing committee member of many International conferences. He served as the Editor-in-Chief of the Korean Society of Stress Medicine and the Executive Editor of Experimental Neurobiology. Prof. Shim's research interests include functional neuroanatomy, neural mechanisms responsible for motivational behaviors including stress, drugs of abuse, learning and memory, and the development of new drugs for neurodegenerative diseases like Parkinson's, Alzheimer's disease, and Ischemia.

Research Keywords & Expertise

Alzheimer's Disease
Animal Behavior
Brain
brain disease
Neurosceience

Fingerprints

40%
Brain
9%
Alzheimer's Disease

Short Biography

Insop Shim is currently working as a Professor in the Department of Medical Science at Kyung Hee University, Republic of Korea. He received his Ph.D. degree in Behavioral Neuroscience from the University of Illinois, USA, and completed his post-doctoral fellowship in the Department of Psychiatry, School of Medicine, University of Illinois. Prof. Insop Shim is a member of the Society for Neuroscience and has served as an organizing committee member of many International conferences. He served as the Editor-in-Chief of the Korean Society of Stress Medicine and the Executive Editor of Experimental Neurobiology. Prof. Shim's research interests include functional neuroanatomy, neural mechanisms responsible for motivational behaviors including stress, drugs of abuse, learning and memory, and the development of new drugs for neurodegenerative diseases like Parkinson's, Alzheimer's disease, and Ischemia.